Pharmacological Control of Autophagy: Therapeutic Perspectives in Inflammatory Bowel Disease and Colorectal Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 26, 2012-09 ,pp. : 3853-3873

Bentham Science Publishers

Access to resources Recommend Favorite

Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances

By Cooper Ziva D   Jones Jermaine D   Comer Sandra D  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 169-178

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological profile of ramosetron, a novel therapeutic agent for IBS

By Hirata T.   Funatsu T.   Keto Y.   Nakata M.   Sasamata M.  

Inflammopharmacology, Vol. 15, Iss. 1, 2007-02 ,pp. : 5-9

Springer Publishing Company

Access to resources Recommend Favorite

GABA A and GABA B receptor agonists, partial agonists, antagonists and modulators: design and therapeutic prospects

By Krogsgaard-Larsen P.   Frolund B.   Kristiansen U.   Frydenvang K.   Ebert B.  

European Journal of Pharmaceutical Sciences, Vol. 5, Iss. 6, 1997-11 ,pp. : 355-384

Elsevier

Access to resources Recommend Favorite

The case for therapeutic proteostasis modulators

By Vij Neeraj  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 3, 2011-03 ,pp. : 233-236

Informa Healthcare

Access to resources Recommend Favorite